Literature DB >> 10548369

Bone mass and metabolism in dermatitis herpetiformis.

M Di Stefano1, R A Jorizzo, G Veneto, L Cecchetti, G Gasbarrini, G R Corazza.   

Abstract

Dermatitis herpetiformis is a gluten-sensitive skin disease with intestinal lesions and malabsorption symptoms less severe than those found in celiac disease. While several studies have shown the occurrence of osteopenia in celiac disease, bone mass and metabolism have never before been evaluated in dermatitis herpetiformis. Therefore, in 16 untreated patients, 16 sex- and age-matched untreated celiac patients, and 16 sex- and age-matched healthy volunteers, lumbar and femoral bone mineral density were measured and bone and mineral metabolism and nutritional status were evaluated. All these parameters were significantly altered in the two groups of patients and although the degree of these alterations was milder in patients with dermatitis herpetiformis than in celiac patients, the presence of subtotal villous atrophy in patients with dermatitis herpetiformis was associated with the presence of more severe alterations. Bone mineral density was significantly correlated with nutritional status, and patients showing bone loss were characterized by a body mass index lower than 20. Alterations of bone mass and mineral metabolism complicate dermatitis herpetiformis when severe intestinal lesions coexist. A low nutritional status may be predictive of the presence of bone loss.

Entities:  

Mesh:

Year:  1999        PMID: 10548369     DOI: 10.1023/a:1026603309056

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  30 in total

1.  Propeptide of type I procollagen is predictive of posttreatment bone mass gain in adult celiac disease.

Authors:  G R Corazza; M Di Stefano; R A Jorizzo; L Cecchetti; L Minguzzi; G Gasbarrini
Journal:  Gastroenterology       Date:  1997-07       Impact factor: 22.682

2.  Dermatitis herpetiformis: an evaluation of diagnostic criteria.

Authors:  L Fry; P P Seah
Journal:  Br J Dermatol       Date:  1974-02       Impact factor: 9.302

3.  The small intestinal mucosa in dermatitis herpetiformis. I. Severity and distribution of the small intestinal lesion and associated malabsorption.

Authors:  J R Brow; F Parker; W M Weinstein; C E Rubin
Journal:  Gastroenterology       Date:  1971-03       Impact factor: 22.682

4.  Dermatitis herpetiformis--a skin manifestation of a generalized disturbance in immunity.

Authors:  M G Davies; R Marks; G Nuki
Journal:  Q J Med       Date:  1978-04

5.  Observer variation in assessment of jejunal biopsy specimens. A comparison between subjective criteria and morphometric measurement.

Authors:  G R Corazza; F Bonvicini; M Frazzoni; M Gatto; G Gasbarrini
Journal:  Gastroenterology       Date:  1982-12       Impact factor: 22.682

6.  Influence of pattern of clinical presentation and of gluten-free diet on bone mass and metabolism in adult coeliac disease.

Authors:  G R Corazza; A Di Sario; L Cecchetti; R A Jorizzo; M Di Stefano; L Minguzzi; G Brusco; M Bernardi; G Gasbarrini
Journal:  Bone       Date:  1996-06       Impact factor: 4.398

7.  Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia.

Authors:  S R Nussbaum; R J Zahradnik; J R Lavigne; G L Brennan; K Nozawa-Ung; L Y Kim; H T Keutmann; C A Wang; J T Potts; G V Segre
Journal:  Clin Chem       Date:  1987-08       Impact factor: 8.327

8.  Subclinical coeliac disease: an anthropometric assessment.

Authors:  G R Corazza; A Di Sario; G Sacco; G Zoli; E A Treggiari; G Brusco; G Gasbarrini
Journal:  J Intern Med       Date:  1994-08       Impact factor: 8.989

9.  Diurnal variation in serum markers of type I collagen synthesis and degradation in healthy premenopausal women.

Authors:  C Hassager; J Risteli; L Risteli; S B Jensen; C Christiansen
Journal:  J Bone Miner Res       Date:  1992-11       Impact factor: 6.741

10.  Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen.

Authors:  J Melkko; S Niemi; L Risteli; J Risteli
Journal:  Clin Chem       Date:  1990-07       Impact factor: 8.327

View more
  4 in total

Review 1.  Evaluation and management of skeletal health in celiac disease: position statement.

Authors:  Mona A Fouda; Aliya A Khan; Muhammad Saad Sultan; Lorena P Rios; Karen McAssey; David Armstrong
Journal:  Can J Gastroenterol       Date:  2012-11       Impact factor: 3.522

Review 2.  Extraintestinal manifestations of coeliac disease.

Authors:  Daniel A Leffler; Peter H R Green; Alessio Fasano
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-08-11       Impact factor: 46.802

3.  Dermatitis herpetiformis: no evidence of bone disease despite evidence of enteropathy.

Authors:  M Abuzakouk; L Barnes; N O'Gorman; A O'Grady; B Mohamed; M J McKenna; R Freaney; C Feighery
Journal:  Dig Dis Sci       Date:  2007-03       Impact factor: 3.487

4.  Self-Reported Fractures in Dermatitis Herpetiformis Compared to Coeliac Disease.

Authors:  Camilla Pasternack; Eriika Mansikka; Katri Kaukinen; Kaisa Hervonen; Timo Reunala; Pekka Collin; Heini Huhtala; Ville M Mattila; Teea Salmi
Journal:  Nutrients       Date:  2018-03-14       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.